Clinical trial
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three…
NCT00200512 · Mylan Bertek Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00200512 |
|---|---|
| Title | Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months |
| Official title | A Prospective, Randomized, Placebo-Controlled, Crossover Study of the Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On/Off" or "Wearing Off" Effects Associated With Late Stage Parkinson's Disease |
| Lead sponsor | Mylan Bertek Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | apomorphine HCl injection |
| Enrollment | 16 |
| Start date | Sep 1, 1999 |
| Completion | Nov 1, 1999 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 16, 2005 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: